Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1974 Feb;53(2):591-9.
doi: 10.1172/JCI107594.

Stimulation of human neutrophil leukocyte aerobic glucose metabolism by purified chemotactic factors

Affiliations

Stimulation of human neutrophil leukocyte aerobic glucose metabolism by purified chemotactic factors

E J Goetzl et al. J Clin Invest. 1974 Feb.

Abstract

The interaction of human neutrophils adherent to plastic petri dishes with the purified chemotactic factors C5a and kallikrein increased their rate of aerobic glycolysis 25-120% and the activity of their hexose monophosphate shunt (HMPS) 100-600%, reaching a plateau after 2 hr at 37 degrees C. The stimulation of either pathway required a chemotactically active stimulus since neither C5 nor prekallikrein or inactivated kallikrein could enhance metabolic activity. Marked suppression of the neutrophil chemotactic response by preincubation with a chemotactic factor to achieve deactivation, 5 x 10(-7) M diisopropyl fluorophosphate, or the neutrophil immobilizing factor (NIF) did not prevent the stimulation of HMPS activity or glycolysis by chemotactic factors. The metabolic inhibitors iodoacetate and 6-aminonicotinamide at concentrations which blocked enhancement of glycolysis or HMPS activity, respectively, partially suppressed the chemotactic response of neutrophils to the chemotactic factors. The capacity of a chemotactic factor to stimulate glucose metabolism of human neutrophils is associated with a maximal chemotactic response, but this stimulation is not alone sufficient for chemotaxis.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Arthritis Rheum. 1965 Dec;8(6):1112-22 - PubMed
    1. Can J Physiol Pharmacol. 1966 May;44(3):475-85 - PubMed
    1. J Exp Med. 1966 Aug 1;124(2):209-26 - PubMed
    1. Clin Chem. 1967 Apr;13(4):314-25 - PubMed
    1. J Exp Med. 1968 Apr 1;127(4):693-709 - PubMed

Publication types